MAIDA ANTHONY E III 4
4 · SPECTRUM PHARMACEUTICALS INC · Filed Jan 25, 2019
Insider Transaction Report
Form 4
MAIDA ANTHONY E III
Director
Transactions
- Sale
Common Stock, $0.001 par value
2019-01-24$10.37/sh−1,550$16,073→ 32,988 total - Sale
Common Stock, $0.001 par value
2019-01-24$10.37/sh−5,700$59,109→ 32,988 total - Exercise/Conversion
Common Stock, $0.001 par value
2019-01-24$3.92/sh+1,550$6,076→ 34,538 total - Exercise/Conversion
Common Stock, $0.001 par value
2019-01-24$5.05/sh+5,700$28,785→ 38,688 total - Exercise/Conversion
Stock Option Exercise (Right to Buy)
2019-01-24−1,550→ 0 totalExercise: $3.92Exp: 2020-07-01→ Common Stock (1,550 underlying) - Exercise/Conversion
Stock Option Exercise (Right to Buy)
2019-01-24−5,700→ 24,300 totalExercise: $5.05From: 2010-06-18Exp: 2020-04-20→ Common Stock (5,700 underlying)
Footnotes (2)
- [F1]All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 16, 2018.
- [F2]The stock option, representing the right to purchase a total of 30,000 shares of common stock, was granted on July 1, 2010. The stock option became exercisable as to 7,500 shares on July 1, 2010, 7,500 shares on July 1, 2011, 7,500 shares on July 1, 2012 and 7,500 shares on July 1, 2013.